Biomerica (BMRA) Capital Expenditures (2010 - 2024)

Biomerica has disclosed Capital Expenditures across 15 years of filings, most recently posting $24000.0 for Q2 2024.

• Capital Expenditures for Q2 2024 came in at $24000.0, changed N/A year-over-year; the trailing twelve-month figure through May 2024 was $51000.0 (down 20.31% YoY), and the FY2024 annual result was $51000.0, down 20.31% from the prior year.
• Capital Expenditures came in at $24000.0 for Q2 2024 at Biomerica, up from $6000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $45194.0 in Q1 2021 to a low of $5141.0 in Q3 2021.
• The 5-year median for Capital Expenditures is $21689.5 (2020), against an average of $20946.3.
• Across the five-year window, Capital Expenditures soared 1723.49% in 2020 and plunged 87.01% in 2021, its largest moves.
• Biomerica's Capital Expenditures stood at $21978.0 in 2020, then sank by 40.53% to $13071.0 in 2021, then soared by 83.61% to $24000.0 in 2022, then slumped by 75.0% to $6000.0 in 2023, then surged by 300.0% to $24000.0 in 2024.
• The last three Capital Expenditures figures came in at $24000.0 (Q2 2024), $6000.0 (Q4 2023), and $21000.0 (Q3 2023), per Business Quant data.